Start
July 11, 2020 - 8:00 am
End
July 11, 2020 - 11:30 am
Cognitive impairment and intellectual disability affect a large population of children suffering from neurodevelopmental diseases as well as the elderly population succumbing to age-associated cognitive impairments. Understanding the molecular mechanisms of these disorders will aid in better diagnosis and improved treatments.
The mini-conference will feature some leading genes causing autism/intellectual disability syndromes, like ADNP and CHD8, as well as electrophysiology and molecular mechanisms of intellectual disability. The role of environmental factors as well as basic mechanisms of synaptic transmission and neuro-glial interactions will also be elucidated. Finally, innovative drug development will be discussed toward better cognitive functioning both in children and elderly.
A collaborative effort between the European Society for Neurochemistry (ESN) and the UK based Simon Initiative for the developing brain will underpin this event.
To view the programme, click here
For further information and registration, please visit event website.
